黑料网

Dear 黑料网 clinical research community, Please see attached a memo detailing future logistical plans for IDS support of clinical trials at Eastowne. We are excited to be supporting the Eastowne initiative and to work with you in shaping the future of medicine. Best,   Andy Thorne, PharmD, MS

Dear SOM Clinical Research Community, Please see attached letter from Senior Associate Vice Chancellor for Research, Andy Johns regarding requirement for approval for clinical research support systems. The notice requires that any unit which proposes to purchase or implement any electronic system or solution for the support of clinical research...

黑料网 Research Community, Beginning next week on Friday 3/5, we will transition to a new pickup procedure for our 3West and Neurosciences hospital IDS locations. Each IP pickup will require verbal confirmation of two patient identifiers: name, DOB, MRN, and/or subject ID. The person picking up from the IDS pharmacy...

A department鈥檚 approval in IRBIS is attesting that the study personnel have the appropriate expertise (e.g., credentialing, licensure, privileges, training), experience (e.g. previous research studies conduct and role in relation to risk level of research), and resources (e.g. committing staff鈥檚 time to appropriately provide oversight, departmental funds if applicable) to...

Dear SOM Clinical Research Community, A major initiative of the CRSO is to support the clinical research workforce through offerings of training materials and courses, development of resources, and implementation of career pathways for research staff. One potential impact related to these initiatives may be improved job satisfaction. We have...

The CRSO and NC TraCS are pleased to announce a new training opportunity for SOM faculty interested in becoming a site investigator for multicenter clinical trials.聽 The聽Clinical Trialist Training Program provides 10% salary support for SOM faculty to participate in both didactic and experiential training, and fosters the development of...

Dear 黑料网 Research Community, Last year, IDS implemented a new billing model on October 1, 2020 that applies to all new studies for which a pharmacist assignment was made on or after Oct 1, 2020. In line with that update, recent changes have been made to the CRMS form to...

The original purpose of the Multi-Site Screening question (#6 on the Screening Questions page) was to distinguish studies that were being conducted at multiple sites from single-site studies. The question was changed last year to address only those instances where 黑料网 is overseeing multiple sites. Older studies were “grandfathered” and...

Conducting clinical research during the COVID-19 pandemic has required us all to adapt and modify our approaches in the conduct of our research in order to successfully navigate the challenges we have faced. As researchers across the nation faced similar challenges, the Clinical Trials Transformation Initiative (CTTI) worked to offer...

Dear Members of the Research Community, As part of the OHRE鈥檚 goal to reduce unnecessary burden and ensure our processes are effective, we continued reviewing application forms to identify improvements and reduce duplication. We started with moving toward application types (e.g., JIT, NHSR, Full Form) and continued by revising the...